✦ LIBER ✦
The BCR–ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy
✍ Scribed by Malcikova, Jitka; Razga, Filip; Jurcek, Tomas; Dvorakova, Dana; Zackova, Daniela; Toskova, Martina; Sebejova, Ludmila; Smardova, Jana; Oltova, Alexandra; Vankova, Gabriela; Jurackova, Lenka; Trbusek, Martin; Pospisilova, Sarka; Mayer, Jiri; Racil, Zdenek
- Book ID
- 120832893
- Publisher
- Informa plc
- Year
- 2013
- Tongue
- English
- Weight
- 244 KB
- Volume
- 54
- Category
- Article
- ISSN
- 1042-8194
No coin nor oath required. For personal study only.